CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., ("Rectify") a biotechnology company developing positive functional modulators (PFMs), small molecule therapeutics ...
BOSTON, May 27, 2026 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, a biotechnology company advancing Positive Functional Modulators (PFMs), a novel class of oral small molecules designed to restore and ...
RTY, Inc., has approached the city of New Philadelphia for financial assistance to maintain the rides at Tuscora Park. Maintenance costs have skyrocketed since Ohio passed Tyler's Law in 2019, which ...
Progressive familial intrahepatic cholestasis type 3 (PFIC3) is a genetic liver disorder caused by mutations in the ABCB4 gene encoding multidrug resistance protein 3 (MCP3) in humans, a biliary ...
A high-level overview of Russell 2000 Index (RTY) stock. View (RTY) real-time stock price, chart, news, analysis, analyst reviews and more.
RTY-694 is a potent, orally active ABCB4/BSEP positive functional modulator (PFM) that improves bile composition and enhances bile flow The differentiated mechanism of a dual-targeted ABCB4/BSEP PFM ...
RTY-406 demonstrates significant improvements in disease relevant endpoints in a mouse model of primary sclerosing cholangitis (PSC) and proof of mechanism in non-human primates RTY-406 is in Phase 1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results